Share Name Share Symbol Market Type Share ISIN Share Description
Oxford Biomedica LSE:OXB London Ordinary Share GB0006648157 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.48p -4.32% 10.62p 10.66p 10.72p 11.98p 10.40p 11.26p 23,341,051 16:35:23
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27.8 -20.3 -0.6 - 329.97

Oxford Biomedica Share Discussion Threads

Showing 101776 to 101799 of 101800 messages
Chat Pages: 4072  4071  4070  4069  4068  4067  4066  4065  4064  4063  4062  4061  Older
DateSubjectAuthorDiscuss
23/1/2018
15:44
thanks small crow. One used to be able to.... ... ah, found it. Euroclear Looks like there was 1.5% short in June That was mostly closed out in July-Sept. Then 0.6% added in Oct and a further 0.25% in Dec. This could relate to Joy selling, or just general hedging movements? ie. could be nothing. It's not large scale shorting of course - would be mad to unless someone had solid info of a discounted placing etc.
stocktastic
23/1/2018
15:23
Although perhaps not ..... what are those % of Santar?
small crow
23/1/2018
15:22
We got through 11p once. We can do it again
volsung
23/1/2018
15:22
Don't think so Doc - you can find number of short positions but not total volume AFAIK.
small crow
23/1/2018
15:21
There you go Doc: https://www.shorttracker.co.uk/company/GB0006648157/
santar
23/1/2018
15:12
Is there still a site that shows short positions in a stock out of interest? I don't expect any material level here, just wondered
stocktastic
23/1/2018
15:07
What its this?!!!! Trader
luxsuspick
23/1/2018
13:55
back to 11.2p I of course included the whole of January in my guess i.e. 1-31 not just the 1st ;0)
bountyhunter
23/1/2018
13:29
'That RNS was the direct cause of the drop' I'd say the unwarranted spike up was the cause of the drop. £30m market cap added for an RNS worth £3 before costs!?
stocktastic
23/1/2018
13:28
That RNS was the direct cause of the drop; buy the rumour sell the fact unless you believe the market doesn't leak!
dr darkstar
23/1/2018
13:10
They are trying hard to encourage sellers with this dip but, you have to say, not having a lot of success. Perhaps Joy finished what they intended??
small crow
23/1/2018
12:50
A highly disappointing retreat from this morning's jump. Need real news rather than these titbits.
sddavies1
23/1/2018
12:37
'PS More importantly, well done doc, totally brilliant guess.' thanks rrr. A more pleasant post than those making pointless unpleasant remarks I'm not going to pretend it was much more than a guess - which was exactly why I gave a range.
stocktastic
23/1/2018
11:56
Novartis seem in no rush. Maybe if Oxb can demonstrate some value apart from the Novartis contracts someone else might take a punt
biopop
23/1/2018
11:46
Doc - you are such a sad case. I really do feel sorry for you.
wiltshireram
23/1/2018
11:43
OXB have tweeted the news now too. Nice to see that as well as the RNS today.
harry s truman
23/1/2018
11:22
Oxford BioMedica announces £3 million grant awarded by Innovate UK London, UK - 23 January 2018: Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, has announced it that has been awarded a £3 million grant by the UK's innovation agency, Innovate UK, to support the UK's efforts to produce viral vectors and ensure adequate supply to meet future demand. Reference: corresponding Innovate UK announcement here: https://www.gov.uk/government/news/improved-healthcare-for-all-pioneering-projects-get-funding The aims of this grant are closely aligned with the current government national priorities to make the UK a global hub for manufacturing advanced therapies, which will benefit economic growth and create and retain more highly skilled employment. The grant will be used to support investment in equipment for vector development, vector manufacture, storage and analytical equipment, as well as other items that are key for the operation of vector GMP facilities. In addition, a small part of the grant will be used to support the planning for the transition of GMP suites from the use of adherent to suspension cultures. John Dawson, Chief Executive Officer of Oxford BioMedica, commented: "We are delighted that the Innovate UK grant will to keep the UK at the forefront of innovation in industrial viral vector manufacturing. Viral vectors are a crucial component of cell and gene therapies, which offer unprecedented promise for the treatment, long-term management or cure of disease. We are pleased that Oxford BioMedica has been selected to contribute our expertise to ensure continued and uninterrupted supply to meet future viral vector demand."
luxsuspick
23/1/2018
11:15
Beanol, I gave my view some posts back, with the convergent triangle indicating 13p by early to mid feb. I suspect that we will need some news to break this resistance level, but if it does then anything is possible as there appears to be a long term head and shoulders pattern forming.
brad1
23/1/2018
11:12
how long will OXB remain independent? any thoughts?
bountyhunter
23/1/2018
11:04
We have a classic bull flag breakout with a projection around 17p in the short term. This is broadly consistent with closing a gap that occurred in mid 2008
dr darkstar
23/1/2018
11:03
What method did you use there?
small crow
23/1/2018
10:43
looks to be going up
mr roper
23/1/2018
10:32
Chartist view anyone?
beanol
23/1/2018
10:25
Little blip to flush a few sellers out and then rejoin that lovely straight line that seems to be pointing to 12.6 (yes, I know it won't, not today anyway).
small crow
Chat Pages: 4072  4071  4070  4069  4068  4067  4066  4065  4064  4063  4062  4061  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20180123 18:20:03